Status:
COMPLETED
Kidney Injury Severity and COVID-19
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University
Conditions:
COVID-19
Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
The authors hypothesize that the SARS-CoV-2 virus can affect the kidneys, causing them to be damaged. The present study aims to explain the mechanisms of kidney injury in patients diagnosed with COVID...
Detailed Description
In December 2019, an outbreak of the 2019 novel coronavirus disease (COVID-19) caused by the SARS coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China. It has spread rapidly to other areas in China and...
Eligibility Criteria
Inclusion
- Pneumonia confirmed by CT scans
Exclusion
- a history of chronic renal failure;
- a history of kidney transplantation;
- intake of substances with a history of renal toxicity (no later than a month before inclusion);
- patients with a single kidney;
- refusal of the patient to participate in the study;
- absence of SARS-CoV-2 virus smear from the nasopharynx in PCR.
Key Trial Info
Start Date :
May 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT04386564
Start Date
May 15 2020
End Date
September 1 2020
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sechenov University.
Moscow, Russia, 119991